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ABSTRACT 39 
To investigate possible association between functional common variants in the lysyl 40 
oxidase like 3 (LOXL3) gene and non-syndromic cleft palate (nsCP) we selected a 41 
common missense variant p.Ile615Phe (rs17010021), which was predicted to have a 42 
probably damaging effect on the LOXL3 enzyme. We genotyped 258 nsCP case-parent 43 
triads of European origin and tested genetic association using the transmission 44 
disequilibrium test (TDT) and log-linear regression analyses of genotypic relative risks 45 
(RR) and of parent-of-origin effects. The observed genotype frequency in parents was in 46 
Hardy-Weinberg equilibrium. Compared with wild-type Ile/Ile homozygotes, the RR for 47 
Phe/Phe homozygote infants was 6.87 (p-value 3.0x10-3), while that for Ile/Phe 48 
heterozygotes was not significant. Assuming an autosomal recessive model, the RR for 49 
Phe/Phe genotype resulted 10.54 (p-value 2.9x10-5), with a 3.6% population attributable 50 
risk. No parental-of-origin effect was observed. The identification in LOXL3 of a 51 
missense variant which under a recessive model associates with ten-fold increased risk 52 
of nsCP supports the hypothesis that the genetic etiology of this congenital anomaly 53 
includes relatively uncommon recessive variants with moderate penetrance and located 54 
in genes which are also involved in syndromes that include CP as part of the phenotype. 55 
Our findings require functional validation and replication in a larger independent 56 
genetic association study. 57 
Key Words: lysyl oxidase like 3, non-syndromic, cleft palate, missense variant.  58 
 59 
60 
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INTRODUCTION 61 
The programming of palatal development starts early in the 4th week, with the 62 
formation of facial primordia that involves a complex series of closely coordinated 63 
events that includes proliferation, differentiation and morphogenetic movement (Dixon 64 
et al. 2011; Mossey et al. 2009). By the end of the 6th week, the primary palate is 65 
formed by the fusion of the medial nasal process with the maxillary process. The 66 
secondary palate arises as bilateral, medially directed outgrowths of the maxillary 67 
processes (palatal shelves) that initially grows vertically on either side of the tongue but 68 
later elevate to a horizontal position above the tongue. This horizontal growth of the 69 
adjacent palatal shelves leads to their contact with one another and fusion to form the 70 
secondary palate (Dixon et al. 2011). Disruption or perturbations at any step during this 71 
process that includes elevation, migration or fusion is likely to induce cleft palate.  72 
Cleft palate (CP) is a common congenital orofacial malformation. Its prevalence at birth 73 
varies with geography and ethnicity between 1 and 25 per 10,000 live births, highest in 74 
non-Hispanic Whites and lowest in Africans (Burg et al. 2016). The sex ratio 75 
(male:female) of CP is 1:2. This might possibly be explained by differential gene 76 
expression as observed between sexes in animal models (Suazo et al. 2011), differential 77 
effects of female hormones (Miura et al. 1990), or delayed fusion of palate in females 78 
(Burg et al. 2016). Approximately 50% of CP cases are non-syndromic (nsCP), (Mai et 79 
al. 2014; Watkins et al. 2014), and are generally considered multifactorial conditions, 80 
due to interplay between genetic and environmental factors (Dixon et al. 2011; Mangold 81 
et al. 2011).  82 
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nsCP shows strong familial aggregation, which suggests a genetic component to 83 
etiology (Marazita & Leslie 2016). Analyses of nationwide records from Norway and 84 
Denmark show an increase in risk of recurrence among first-degree relatives of affected 85 
individuals (Sivertsen et al. 2008; Grosen et al. 2010). The environmental factors 86 
contributing to CP etiology so far identified are largely the same as those for cleft of the 87 
lip and palate (CL/P) including tobacco smoke and alcohol (Little et al. 2004; Sabbagh 88 
et al. 2015; Bell et al. 2014) and an inverse association with reported maternal use of 89 
vitamin supplements (Butali et al. 2013). 90 
A number of genetic factors associated with non-syndromic oral clefts have been 91 
identified, mainly for CL/P rather than CP. Based on these genetic findings, non-92 
syndromic CL/P and non-syndromic CP are considered to have only very limited 93 
overlap in terms of their genetic etiology (Cura et al. 2016). This is further supported by 94 
genome-wide association studies (GWASs) or meta-analyses of GWAS data in different 95 
populations that have identified 37 risk loci for non-syndromic CL/P (Birnbaum et al. 96 
2009; Mangold et al. 2010; Beaty et al. 2010, 2013; Leslie et al. 2015, 2017; Yu et al. 97 
2017; Ludwig et al. 2017; Ludwig et al. 2017; Ishorst et al., 2018), but just one 98 
replicated finding for non-syndromic CP (Leslie et al. 2016; Mangold et al. 2016).  99 
Although GWAS have helped detect and replicate associations between common gene 100 
variants and orofacial clefts, the proportion of heritability accounted for by these 101 
variants is relatively low, with inconsistencies across studies (Beaty et al. 2016). GWAS 102 
have typically been designed to minimize the risk of false positive genetic associations 103 
in common chronic disease, but it is known that there is a substantial risk of false 104 
negatives (Ioannidis et al. 2011). Moreover, it has been observed that common variants 105 
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of genes that are involved in Mendelian disorders have been associated with non-106 
Mendelian forms of the same disorders (Blair et al. 2013). In addition, variants of some 107 
genes involved in syndromic clefts have been found to have replicated associations with 108 
non-syndromic clefts, reflecting the two forms of clefting as parts of a single spectrum 109 
(Stanier & Moore 2004; Dixon et al. 2011). An excellent example is GRHL3, the second 110 
gene associated with Van der Woude syndrome and its recent identification as 111 
associated with nsCP (Leslie et al. 2016; Mangold et al. 2016).  112 
The human LOXL3 gene located on chromosome 2p13.1 has been associated with 113 
Stickler syndrome (MIM #108300), which includes CP as a phenotype (Alzahrani et al. 114 
2015). Additionally, deletion of this gene impairs collagen assembly and crosslinking 115 
during palate development in mouse model (Zhang et al. 2015). However, no evidence 116 
of linkage or association with nsCP was reported for this gene in a recent GWAS 117 
(Leslie et al. 2016) or an imputation based meta-analysis of GWAS data (Ludwig et al. 118 
2017).  Of note, the ability to detect common variants with very weak effects, or less 119 
common variants with small to modest effects, is strongly dependent on assumptions 120 
concerning linkage disequilibrium, allele frequency and genotype certainty (Bomba et 121 
al. 2017).  122 
We therefore examined the potential association between putative functional variants of 123 
LOXL3 and nsCP, a disorder that is less common than other nsCL/P in humans, and less 124 
investigated, in European case-parent triads. 125 
 126 
MATERIALS AND METHODS  127 
Participants 128 
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The study includes 258 nuclear families of infants with nsCP identified through the 129 
EUROCRAN and ITALCLEFT biobanks, which include case-parent trios from 9 130 
European countries (Mossey et al. 2017; Ghassibe-Sabbagh et al. 2011), including the 131 
United Kingdom, Netherlands, Italy, Spain, Slovenia, Slovakia, Hungary, Estonia and 132 
Bulgaria. The case-parent trio design of the present study makes it less vulnerable to 133 
population stratification, a particular concern of multi-centre studies [Mossey et al. 134 
2017]. Ethical permission was sought and obtained at surgical centres in each 135 
participating countries at the time of first surgical intervention on the index infant. 136 
Infants with recognized syndromic clefts or Pierre Robin sequence were excluded. 137 
Peripheral blood or buccal cell samples were used to obtain genomic DNA from infants 138 
and their parents. The use of data and DNA samples from EUROCRAN and 139 
ITALCLEFT biobanks was approved by MREC Scotland (Dec 7th 2011, #MREC/1/0/7) 140 
and S. Paolo Hosp. E.C. (Mar 2nd, 2012, #3503) respectively. 141 
Exposure information 142 
In both the EUROCRAN and ITALCLEFT studies mothers were asked to respond to a 143 
specific questionnaire that was administered by personal interview when the index 144 
affected infant was brought in to the surgical centre to undergo the primary surgery. 145 
Major areas about which information was sought included use of nutritional 146 
supplements and tobacco smoking. Folic acid supplementation was defined as having 147 
taken folic acid or folic acid-containing supplements (at least 0.4 mg/day) for at least 148 
one month during the periconceptional period (3 months before to 3 months after 149 
conception). Maternal smoking during pregnancy was defined as having smoked at least 150 
one cigarette per day during the periconceptional period (Mossey et al. 2017). 151 
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Selection of putative functional single nucleotide variants in LOXL3 152 
We screened the exons of the LOXL3 gene for nucleotide substitutions and insertions 153 
and deletions using the UCSC Genome browser GRCh38/hg38 assembly 154 
(https://genome-euro.ucsc.edu/) and identified 336 missense and 139 synonymous 155 
variants. Of these, according to dbSNP build 150 156 
(www.ncbi.nlm.nih.gov/projects/SNP), only three are polymorphic, with minor allele 157 
frequency (MAF) >1%: rs17010022, rs17010021, and rs77706750. The first SNP, 158 
rs17010022, is a synonymous p.Leu371Leu variant located in exon 7 of LOXL3 gene, 159 
with putative no effect on conformation of the encoded peptide, and therefore was 160 
discarded. The other two variants, rs77706750 in exon 7, and rs17010021 in exon 11, 161 
cause substitutions (p.Arg375His and p.Ile615Phe, respectively) both predicted to be 162 
“probably damaging” by PolyPhen-2 (Adzhubei et al. 2013). However, considering the 163 
available sample size, the MAF of rs77706750 was too low (1.46%) to provide enough 164 
power (0.80) under dominant or recessive genetic models (Quanto 1.2.4, 165 
biostats.usc.edu), and hence was not included in the present study. However, the MAF 166 
of rs17010021 was much higher (8.23% reported in dbSNP), granting sufficient power 167 
for a genetic association study. 168 
Genotyping  169 
For most individuals included in the study, genomic DNA (gDNA) was extracted from 170 
peripheral blood specimens using the Nucleon BACC1 kit (Amersham Biosciences, part 171 
of GE Healthcare Europe, CH). For around 5% of participants, gDNA was extracted 172 
from buccal swab specimens using QIAamp DNA Blood Mini Kit (Qiagen, Hilden DE) 173 
according to the manufacturer’s instructions. All gDNA samples were quantified using 174 
Qubit® dsDNA BR Assay Kit (Life technologies Oregon, USA).  175 
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Genotypes of p.Ile615Phe variant were obtained by TaqMan allelic discrimination assay 176 
using an ABI 7300 real-time thermocycler according to the standard protocol of 177 
manufacturer (Applied BioSystems, Foster City, CA). In 15% of samples, genotyping 178 
was repeated for quality testing. 179 
 Statistical analysis 180 
The χ2 test for the Hardy-Weinberg equilibrium (HWE) were computed for genotypes 181 
of parents and case-infants. The genetic association of the missense variant in nsCP 182 
case-parent triads was calculated using the transmission disequilibrium test (TDT), 183 
(Spielman et al. 1993). We estimated relative risk (RR) and 95% of confidence interval 184 
(CI) for the independent effects of mother and infant genotypes using a log-linear 185 
regression model that incorporates an expectation-maximization algorithm to allow 186 
inclusion of triads for which both parent genotype were missing (Weinberg et al. 1998; 187 
Wilcox et al. 1998). The analyses were implemented using the Stata package 188 
(http://www.biostat-resources.com, StataCorp LP, College Station, TX). As exploratory 189 
analyses, we carried out subgroup analyses stratifying on the sex of the infant and 190 
maternal smoking and use of supplements containing folic acid.  191 
We further investigated a possible parent-of-origin effect, by assessing the risk 192 
increment (IM) in the offspring associated with receiving the allele transmitted from the 193 
mother as compared to the father in log-linear regression analysis (Weinberg et al. 1998; 194 
Wilcox et al. 1998).  195 
 196 
RESULTS 197 
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The study included 258 nsCP case-parent trios from 9 European countries. As expected, 198 
female cases outnumbered the males, and male:female sex ratio was 0.78 (95% C.I. 199 
0.74-0.84).   200 
The allele and genotype frequency of the triads included in the study is shown in Table 201 
1. Among the 516 parents included in the study the frequency of Phe allele was 4.7% 202 
(95%CI 2.9-6.5%), a value lower than the 8.23% reported in dbSNP. Genotype 203 
frequency among cases was significantly out of Hardy-Weinberg equilibrium (p-value = 204 
2.27x10-6), while both parents resulted not in disequilibrium (p-value = 0.68). 205 
Remarkably, the frequency of Phe/Phe homozygotes, predicted to be only 0.22% on the 206 
basis of allele frequency in the parents, was 7-fold higher (1.55%) than predicted among 207 
nsCP cases. 208 
Application of TDT showed no significant evidence of asymmetric segregation of Phe 209 
allele from parents (Transmitted:Non-transmitted = 21:23, p-value = 0.673). 210 
Considering the observed low frequency of Ile/Phe genotype among parents (Table 1),  211 
and being the power of the TDT heavily dependent on the number of heterozygous 212 
parents (Sebro, Rogus, 2010), we performed the calculation of genotype-associated RR 213 
using a log-linear regression model (Weinberg et al. 1998; Wilcox et al. 1998). 214 
Calculation of genotype-associated RR showed significant association between Phe/Phe 215 
homozygous infant genotype and nsCP risk (RR = 6.9, p-value = 0.003), whereas there 216 
was no significant association with the heterozygous genotype. Mother’s genotype was 217 
not associated with increased risk of nsCP in the offspring (Table 2). 218 
Considering that the Ile/Phe genotype provided no increased risk of nsCP compared to 219 
wild type Ile/Ile homozygotes, while Phe/Phe genotype associated with increased risk, 220 
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we assumed a recessive genetic model. Under this model, log-linear regression analysis 221 
showed that infant’s Phe/Phe genotype associated with a significant ten-fold increased 222 
risk of nsCP (RR = 10.54 (95% C.I. 3.34-33.30, p-value = 2.85x10-5). No parental of 223 
origin effect was observed (IM = 0.58, p-value = 0.455). 224 
Considering the genotypic frequencies of parents as reference and a birth prevalence of 225 
nsCP of 1:2216 among Europeans (Calzolari et al., 2004), the population attributable 226 
risk of Phe/Phe genotype was 3.6%, whereas the penetrance was 0.48%.   227 
Although we are aware of the limited sample size of our study, we conducted subgroup 228 
analyses and report these. Among the four Phe/Phe infants, three females and one male, 229 
only one girl was born from a mother exposed to folic acid supplementation during the 230 
periconceptional period. As regards periconceptional exposure to tobacco smoking, all 231 
four Phe/Phe infants were born from non-smoking mothers. RR did not significantly 232 
differed between male and female cases. 233 
  234 
DISCUSSION 235 
In the present study, we investigated a potential association between functional common 236 
variants in lysyl oxidase like 3 (LOXL3) gene and the risk of developing nsCP. Rare 237 
variants in LOXL3 have been detected in patients with Stickler syndrome, which may 238 
present with CP (Alzahrani et al. 2015), and in mouse model a crucial role of Loxl3 239 
gene in palate development has been demonstrated (Zhang et al. 2015). Among the 240 
hundreds of missense variants annotated in LOXL3 gene we selected p.Ile615Phe, which 241 
is the only one that is predicted to be probably damaging and has relatively high MAF, 242 
sufficient to provide enough statistical power considering the sample size of the study. 243 
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Although Phe/Phe homozygotes are very uncommon, we identified four Phe/Phe 244 
homozygotes among the 258 cases included in the study, and detected a significant 245 
association between infant’s homozygote Phe/Phe genotype and the risk of nsCP, 246 
compared to common Ile/Ile homozygotes. Heterozygous Ile/Phe genotype was not 247 
significantly associate with nsCP. Therefore, assuming an autosomal recessive model, 248 
the Phe/Phe genotype turned out to associate with around ten-fold increased risk of 249 
nsCP (p-value = 2.85x10-5). Autosomal recessive genetic model is typical for enzyme-250 
encoding genes, and fits well with the nature of LOXL3. As the p.615Phe enzyme is 251 
predicted to have lost most or all catalytic activity, we presume that Phe/Phe 252 
homozygotes are severely deficient of the amine oxidase activity of LOXL3 enzyme, 253 
and consequently have impaired collagen fiber assembly in palatal mesenchyme. We 254 
hypothesize that this impairment could have played a role in determining the failure of 255 
fusion of palatal shelves during embryogenesis, and ultimately caused CP. The lack of 256 
efficient catalysis of collagen crosslinking associated with p.615Phe enzyme may 257 
resemble the effect of LOX’s inhibitor β-aminopropionitrile, which determine reduced 258 
collagen fibres density and development of CP in animal model (Pratt & King 1972). 259 
Functional studies using animal models are awaited to confirm the phenotypic effect of 260 
p.615Phe enzyme. 261 
The failure of TDT to detect association could rely on the fact that, due to the relative 262 
low MAF of the studied LOXL3 variant, among the cases most of p.615Phe alleles are 263 
carried by heterozygotes, which are not at risk of nsCP, and therefore distortion of 264 
transmission from parents would not be expected.    265 
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As might be anticipated for a gene expressed in palate shelves during embryonic 266 
development, maternal p.Ile615Phe genotype was not associated with the infant’s risk 267 
of nsCP. Moreover, no preferential transmission of minor allele from one of two parents 268 
was observed. Due to the low frequency of Phe/Phe homozygotes, the statistical power 269 
of the study was not sufficient to detect interaction with infant sex, periconceptional 270 
folic acid supplementation, or exposure to tobacco smoking.  271 
The infant’s Phe/Phe genotype seems to strongly increase the risk of nsCP, but its actual 272 
weight among the multiple genetic and environmental factors as part of the 273 
multifactorial etiology of nsCP is relatively small. Due to the relatively low MAF of 274 
p.Ile615Phe, the calculated population attributable risk was only 3.6%, and the 275 
penetrance modest (0.48%). We hypothesize that other functional variants of the LOXL3 276 
gene, mainly classified as rare variants and less frequent than the p.Ile615Phe variant, 277 
might be associated with nsCP risk. 278 
The impact of rare or less common variants associated with increased risk of nsCP has 279 
begun to emerge from recent exome-wide and genome-wide sequencing studies 280 
(Mangold et al. 2016). In particular, a low frequency missense p.Thr454Met variant in 281 
GRHL3 (rs41268753) was significantly associated with nsCP risk (Mangold et al. 2016; 282 
Leslie et al. 2016). From the latest genetic investigations on nsCP, a difference in terms 283 
of frequency spectrum of susceptibility variants compared to nsCL/P, is becoming 284 
evident. While GWAS of nsCL/P identified a number of common polymorphic variants  285 
(Birnbaum et al. 2009; Beaty et al. 2010; Mangold et al. 2010), GWAS of nsCP have 286 
detected only one genome-wide significant variant (Leslie et al. 2016), even though 287 
sample size were comparable. This evidence suggests that the genetic aetiology of nsCP 288 
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may mainly rely on relatively rare variants, or less common variants that act under 289 
recessive model, which may present moderate penetrance, tending to escape detection 290 
by genome-wide studies and to be located within genes involved in syndromes that 291 
include CP as part of the phenotype. LOXL3 p.Ile615Phe may be one of these variants. 292 
In conclusion, using a candidate gene approach, we identified a missense variant in 293 
LOXL3 gene, p.Ile615Phe, which under a recessive model is associated with a 294 
significant ten-fold increased risk of nsCP. This finding should be replicated in a larger 295 
cohort of case-parent trios, and joint effects with environmental exposure factors 296 
investigated. We suggest that LOXL3 p.Ile615Phe, along with GRHL3 p.Thr454Met, are 297 
part of a constellation of low frequency variants that compose the genetic background of 298 
nsCP. 299 
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Table 1 Allele and genotype frequencies of p.Ile615Phe (rs17010021) in 258 435 
nsCP case-parent triads, and p-value of difference from Hardy-Weinberg (H-W) 436 
equilibrium. 437 
 438 
Alleles/Genotypes 
Cases 
 n (%) 
Mothers 
n (%) 
Fathers 
n (%) 
Ile 493 (95.5) 498 (96.5) 486 (94.2) 
Phe 23 (4.5) 18 (3.5) 30 (5.8) 
Ile/Ile 239 (92.6) 240 (93.0) 230 (89.1) 
Ile/Phe 15 (5.8) 18 (7.0) 26(10.1) 
Phe/Phe 4 (1.6) 0 (0.0) 2 (0.8) 
H-W p-value 2.27 x 10-6 0.85 0.44 
439 
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Table 2 Genotype-associated relative risk of p.Ile615Phe (rs17010021) in 258 440 
nsCP case-parent triads assuming the common Ile/Ile homozygous genotype as 441 
reference. 442 
 443 
Mother’s genotypes RR (95% C.I.) p-value 
Ile/Phe 0.54 (0.28-1.05) 0.071 
Phe/Phe n.c. - 
Infant’s genotypes RR (95% C.I.) p-value 
Ile/Phe 0.61 (0.31-1.17) 0.136 
Phe/Phe 6.87 (1.97-23.98) 0.003 
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